Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenol Neurolysis for Knee Osteoarthritis Pain
NCT04989660Phase 4Unknown
- Sponsor
- Kessler Foundation
- Start
- Nov 2021
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of phenol in osteoarthritis (OA) (2 arms), sponsored by Kessler Foundation. Primary endpoint: Numeric Rating Scale Pain Score at 6 months. Status: unknown.
02
Drugs
phenol
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04989660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04989660.